Marsh & Mclennan Companies, Inc.

Company facts

Industry

Insurance Agents, Brokers & Service

Headquarters

New York, New York

Most recent report

10-Q, filed Jul 21, 2026

Incorporated

Delaware

Filings on record

1,002+ filings

On EDGAR

CIK 62709

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Jun 2026 10-Q

SECSift found 2 of 13 sections worth reading, with 3 positive, 4 notable, and 4 negative flags.

• Financial Statements (Item 1)

  Financial statements with a $425M litigation reserve and a $1.5B buyback pace shift.
  Notable

  • Commercial paper outstanding $1.0B at June 30, 2026; program raised to $4.25B.
  • $500M three-year Thrive restructuring program; $239M incurred through June 30, 2026.
  • Repurchased $1.5B of shares in H1 2026 vs $600M in H1 2025.
  Negative

  • $425M gross liability recorded for Greensill litigation; trial set for September 2026.

• Management's Discussion (Item 2)

  Greensill charge, Thrive costs, debt shifts, segment divergence, material company-specific results.
  Positive

  • Q2 2026 revenue $7.4B, +6% (+5% underlying); EPS $2.63, +7%.
  • Consulting Q2 2026 revenue $2.6B, +10% (+8% underlying); operating income $502M vs $456M.
  • Quarterly dividend raised to $0.990 per share in July 2026, up from $0.900.
  Notable

  • U.K. pension surplus: no deficit funding required until 2029; prior support agreement not renewed.
  Negative

  • YTD 2026 operating income $3.7B, -5%; diluted EPS $4.99, -5% due to $425M Greensill charge.
  • Guy Carpenter Q2 2026 revenue $664M, -2% reported and underlying, hurt by declining reinsurance premium rates.
  • Operating cash flow $835M in H1 2026, down from $1.0B in H1 2025.

What changed: Jun 2026 vs. Mar 2026

About 10% of MRSH's Jun 2026 10-Q is new information. 52 paragraphs were added, 181 changed, and 19 removed. Below are the most important lines SECSift identified.

• Item 2 103
• Item 1 81
• Item 3 4
• Item 6 3